CD274 and cancer: Effector T lymphocytes can attack and kill cancer cells; however, some cancer cells express PD-L1 on their surface as an immunosuppressive strategy, deactivating the T cell response upon the binding of their PD-L1 with the PD-1 receptors of T cells.